Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T McNutt

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Dairy Science|May 1, 1989
Evaluation of butylated hydroxytoluene as a cryopreservative added to whole or skim milk diluent for bull semenG Killian, T Honadel, T McNutt, et al.
Journal of Cheminformatics|March 2, 2025
GNINA 1.3: the next increment in molecular docking with deep learningAndrew T McNutt, Yanjing Li, Rocco Meli, et al.
Medical Physics|October 1, 1996
A consistency monitor for radiation therapy treatmentsB R Paliwal, M Zaini, T McNutt, et al.
Journal of Chemical Information and Modeling|October 30, 2023
Conformer Generation for Structure-Based Drug Design: How Many and How Good?Andrew T McNutt, Fatimah Bisiriyu, Sophia Song, et al.
Neurology|November 13, 2002
Fulminant ascending paralysis as a delayed sequela of diethylene glycol (Sterno) ingestionY D Rollins, C M Filley, J T McNutt, et al.
Journal of Cheminformatics|June 10, 2021
GNINA 1.0: molecular docking with deep learningAndrew T McNutt, Paul Francoeur, Rishal Aggarwal, et al.
Arxiv|February 20, 2025
Scaling Structure Aware Virtual Screening to Billions of Molecules with SPRINTAndrew T McNutt, Abhinav K Adduri, Caleb N Ellington, et al.
AJNR. American Journal of Neuroradiology|May 8, 2010
Low cerebellar vermis volumes and impaired neuropsychologic performance in children treated for brain tumors and leukemiaA Horská, A Laclair, M Mohamed, et al.
Seminars in Radiation Oncology|April 10, 1999
TomotherapyT R Mackie, J Balog, K Ruchala, et al.
Frontiers in Pharmacology|January 24, 2025
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicityAboli Bhingarkar, Yuyin Wang, Keito Hoshitsuki, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Dairy Science|May 1, 1989
Evaluation of butylated hydroxytoluene as a cryopreservative added to whole or skim milk diluent for bull semenG Killian, T Honadel, T McNutt, et al.
Journal of Cheminformatics|March 2, 2025
GNINA 1.3: the next increment in molecular docking with deep learningAndrew T McNutt, Yanjing Li, Rocco Meli, et al.
Medical Physics|October 1, 1996
A consistency monitor for radiation therapy treatmentsB R Paliwal, M Zaini, T McNutt, et al.
Journal of Chemical Information and Modeling|October 30, 2023
Conformer Generation for Structure-Based Drug Design: How Many and How Good?Andrew T McNutt, Fatimah Bisiriyu, Sophia Song, et al.
Neurology|November 13, 2002
Fulminant ascending paralysis as a delayed sequela of diethylene glycol (Sterno) ingestionY D Rollins, C M Filley, J T McNutt, et al.
Journal of Cheminformatics|June 10, 2021
GNINA 1.0: molecular docking with deep learningAndrew T McNutt, Paul Francoeur, Rishal Aggarwal, et al.
Arxiv|February 20, 2025
Scaling Structure Aware Virtual Screening to Billions of Molecules with SPRINTAndrew T McNutt, Abhinav K Adduri, Caleb N Ellington, et al.
AJNR. American Journal of Neuroradiology|May 8, 2010
Low cerebellar vermis volumes and impaired neuropsychologic performance in children treated for brain tumors and leukemiaA Horská, A Laclair, M Mohamed, et al.
Seminars in Radiation Oncology|April 10, 1999
TomotherapyT R Mackie, J Balog, K Ruchala, et al.
Frontiers in Pharmacology|January 24, 2025
Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicityAboli Bhingarkar, Yuyin Wang, Keito Hoshitsuki, et al.
Pageof 3